THE first adult addition to the National Immunisation Program (NIP) in a decade, Zostavax, marketed in Australia by CSL's vaccine arm Seqirus, has been announced by the Department of Health.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 20 Oct 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Oct 16
